See the latest in our stock-picking competition: which stocks are hot and what the top 10 looks like. And you can still register if you haven't done so yet!
Another week has gone by for the "Diagnose the Dow" stock contest, but the top 10 has seen only minor changes as participants make their stock picks.
For those participants with Amarin in their portfolios the biopharmaceutical company has treated them well
they’re seeing profits of more than 50%. The number of stocks in a portfolio seems to have no bearing on how a participant is doing. The top 10 portfolios range in size from just two stocks to 24.
Since opening the contest up to stocks from all sectors, participants have really broadened their portfolios with a mix of pharmaceutical, retail, technology, oil companies and more.
At the beginning of the contest, Mylan and Teva had been popular, but now the former shows up in only two of the top 10 portfolios and the latter in just one. Apple is being held in four of the top 10, Biogen in three, and Amarin and Allergan each in two.
Here is the top 10 as it stood at the end of week 3:
For the most part, the same names continue to show up in the top 10. Think you know better? Register and make your own picks!
Join our game and invest $100,000 of virtual funds in any stocks you choose. Placing trades is easy and fun! Then check back in daily to see how your stock picks are performing against your competitors. The winner will receive an iPad, while four (4) runners up will receive $50 AmEx gift cards.
Registration will remain open until the end of the contest on April 27, 2012.